University of California San Francisco

Alexander Murphy, MD

Alexander Murphy
Alexander Murphy, MD

Resident Research Fellow
Plastic Surgery

[email protected]

Education

Institution Degree Dept or School End Date
Columbia University MD 05/2022
University of Pennsylvania BA 05/2016

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 10
  1. Cardiac Safety Outcomes in Delandistrogene Moxeparvovec Clinical Trials for Duchenne Muscular Dystrophy with Up to 5 Years of Follow-up.
    Veerapandiyan A, Bourke J, Soslow JH, Day JW, McDonald CM, Mendell JR, Zaidman CM, Mason S, Meng J, Vivien M, Murphy AP, Wandel C, Richardson J| | PubMed
  2. Lipid nanoparticles for nucleic acid delivery to osteoblasts and osteoblast-lineage cells: A systematic review.
    Murphy AI, Vargas C, Pomerantz JH| | PubMed
  3. Two-Year Outcomes Following Delandistrogene Moxeparvovec Treatment in Ambulatory Patients with Duchenne Muscular Dystrophy: Phase 3 EMBARK Trial.
    Mendell JR, Muntoni F, McDonald CM, Mercuri EM, Ciafaloni E, Komaki H, Leon-Astudillo C, Nascimento A, Proud C, Schara-Schmidt U, Veerapandiyan A, Zaidman CM, Furgerson M, Ding K, Singh P, Potter R, Asher DR, Murphy AP, Reid C, Hooper G, Torre CO, Manfrini M, Rodino-Klapac LR| | PubMed
  4. Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapy.
    Potter RA, Moeller IH, Khan S, Haegel H, Hollenstein A, Steiner G, Wandel C, Murphy AP, Asher DR, Palatinsky E, Griffin DA, Mason S, Iannaccone ST, Zaidman CM, Rodino-Klapac LR| | PubMed
  5. Caregiver Global Impression Observations from EMBARK: A Phase 3 Study Evaluating Delandistrogene Moxeparvovec in Ambulatory Patients with Duchenne Muscular Dystrophy.
    McDonald CM, Elkins JS, Dharmarajan S, Gooch K, Ciobanu T, Lansdall CJ, Murphy AP, McDougall F, Mercuri EM, Audhya I, EMBARK Study Group| | PubMed
  6. AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial.
    Mendell JR, Muntoni F, McDonald CM, Mercuri EM, Ciafaloni E, Komaki H, Leon-Astudillo C, Nascimento A, Proud C, Schara-Schmidt U, Veerapandiyan A, Zaidman CM, Guridi M, Murphy AP, Reid C, Wandel C, Asher DR, Darton E, Mason S, Potter RA, Singh T, Zhang W, Fontoura P, Elkins JS, Rodino-Klapac LR| | PubMed
  7. The Devil's in the Depot Details: Case of Iatrogenic Opioid Intoxication After Buprenorphine Injection Requiring Surgical Excision.
    Vais S, Starr N, Castro M, Brand N, Murphy A, Tesoriero R, Kryzhanovskaya I| | PubMed
  8. Reply: Lymphatic Microsurgical Preventative Healing Approach for the Primary Prevention of Lymphedema: A 4-Year Follow-Up.
    Murphy AI, O'Connell GM, Ishtihar S, Levy AS, Rohde CH| | PubMed
  9. Functional donor-site morbidity following reconstruction with pectoralis major flaps: A systematic review.
    Falade IO, Murphy AI, Switalla KM, Yin RR, Rose JA| | PubMed
  10. Practical Considerations for Delandistrogene Moxeparvovec Gene Therapy in Patients With Duchenne Muscular Dystrophy.
    Mendell JR, Proud C, Zaidman CM, Mason S, Darton E, Wang S, Wandel C, Murphy AP, Mercuri E, Muntoni F, McDonald CM| | PubMed